<SEC-DOCUMENT>0000087802-13-000007.txt : 20130627
<SEC-HEADER>0000087802-13-000007.hdr.sgml : 20130627
<ACCEPTANCE-DATETIME>20130627102733
ACCESSION NUMBER:		0000087802-13-000007
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20130612
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20130627
DATE AS OF CHANGE:		20130627

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SCIENTIFIC INDUSTRIES INC
		CENTRAL INDEX KEY:			0000087802
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				042217279
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-06658
		FILM NUMBER:		13936256

	BUSINESS ADDRESS:	
		STREET 1:		70 ORVILLE DR
		STREET 2:		AIRPORT INTERNATIONAL PLZ
		CITY:			BOHEMIA
		STATE:			NY
		ZIP:			11716
		BUSINESS PHONE:		6315674700

	MAIL ADDRESS:	
		STREET 1:		70 ORVILLE DR
		CITY:			BOHEMIA
		STATE:			NY
		ZIP:			11716
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>biodox.txt
<TEXT>
     SECURITIES AND EXCHANGE COMMISSION
           Washington, D.C. 20549


                     FORM 8-K
                  CURRENT REPORT

        PURSUANT TO SECTION 13 OR 15(d)
   OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 27, 2013


             SCIENTIFIC INDUSTRIES, INC.
______________________________________________________
(Exact name of registrant as specified in its charter)

Delaware	    000-6658        04-2217279
_______________	  _____________  __________________
(State or other   (Commission    (IRS Employer No.)
jurisdiction of    File Number)
incorporation)

                   70 Orville Drive
                Bohemia, New York 11716
__________________________________________________
   (Address of principal executive offices)


                   (631) 567-4700
__________________________________________________
Registrant's telephone number, including area code


                    Not Applicable
__________________________________________________
(Former name or former address,
if changed since last report)


ITEM 1.02.  Termination of a Material Definitive Agreement


See Item 8.01 for termination of the Research and Development
Agreement between BioDox R&D Corporation and the Company's
subsidiary, Scientific Bioprocessing, Inc.

ITEM 8.01.  Termination of a Material Definitive Agreement

In June 2013, Scientific Bioprocessing, Inc, a wholly-owned
subsidiary of the Company, terminated its Research and
Development Agreement with BioDox R&D Corporation
(the "Developer") formerly Fluorometrix Inc., pursuant to
Section 7.2(b)(iii) of the Agreement due to the death of
Dr. Joseph E. Qualitz, the Developer's Chief Operating Officer.
The R&D Agreement provides that the Agreement terminate
immediately upon the cessation of Qualitz "to carry out and be
responsible for the day-to-day business operation of Developer
unless the Company consents in writing to a replacement who has
similar skills, education, experience and capabilities."  The
Company believes that the termination will not be materially
adverse to the Company's operation or financial condition as it
believes the research and development can be performed by its
staff, or if needed, through qualified subcontractors at no
additional material increase in cost from that to be incurred
if the agreement was not terminated.


ITEM 9.01  Financial Statements and Exhibits

(a) and (b) not applicable

(c) Exhibits

Exhibit No.      Exhibit
___________      _____________________________
99.1             Research and Development Agreement between
	         Scientific Bioprocessing, Inc, and BioDox
		 R&D Corporation, dated November 14, 2011
		 (incorporated hereto by reference to Exhibit 10(B)
		 to Current Report on Form 8-K, dated November 14, 2011)

99.2		 Notice of Termination of Reseearch and Development
	         Agreement


                            SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.


                                   SCIENTIFIC INDUSTRIES, INC.
                                   (Registrant)


Date:	June 27, 2013
			           By: /s/ Helena R. Santos
                                   ________________________

			           Helena R. Santos,
			           President and Chief Executive
 			           Officer


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1 CHARTER
<SEQUENCE>2
<FILENAME>biolettr.txt
<TEXT>
             Scientific Bioprocessing, Inc.
                  70 Orville Drive
                Bohemia, New York 11716


					June 12, 2013


BioDox R&D Corporation
24 Timber Edge Road
Stow, Massachusetts 01775


Gentlemen:

	Please be advised that due to the death of Dr. Joseph
E. Qualitz, Scientific Bioprocessing, Inc. (the "Company") has
determined pursuant to Section 7.2(b)(iv) of the Research and
Development Agreement dated November 14, 2011 between the
Company and BioDox R&D Corporation (the "Developer"), to
terminate the Agreement effective immediately.


			        Very truly yours,

			        SCIENTIFIC BIOPROCESSING, INC.


				BY: /S/ HELENA R. SANTOS
                                _____________________
 				Helena R. Santos, President


cc:   Mr. Thomas Alexander
      c/o Fluorometrix Corporation
      15913 S. Windy City Road
      Mulino, OR 97042

      Donna Qualitz
      BioDox R&D Corporation
      P.O. Box 816,
      Stow MA 01775


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>